BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12691147)

  • 1. Pneumonia in acute leukemia patients during induction therapy: experience in a single institution.
    Specchia G; Pastore D; Carluccio P; Mele G; Montagna MT; Liso A; Rizzi R; Ianora AS; Liso V
    Leuk Lymphoma; 2003 Jan; 44(1):97-101. PubMed ID: 12691147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens.
    Rossini F; Verga M; Pioltelli P; Giltri G; Sancassani V; Pogliani EM; Corneo G
    Haematologica; 2000 Dec; 85(12):1255-60. PubMed ID: 11114131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumonia during remission induction chemotherapy in patients with acute leukemia.
    Garcia JB; Lei X; Wierda W; Cortes JE; Dickey BF; Evans SE; Ost DE
    Ann Am Thorac Soc; 2013 Oct; 10(5):432-40. PubMed ID: 23987587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.
    Kang KW; Kim DS; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim BS; Park Y
    Leuk Res; 2017 Jun; 57():1-8. PubMed ID: 28231491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daunorubicin 90 mg/m
    Portugal R; Lyrio R; Loureiro M; Urago K; Bard J; Borchardt A; Garnica M; Nucci M
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):527-531. PubMed ID: 28842139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
    Bow EJ; Gallant G; Williams GJ; Woloschuk D; Shore TB; Rubinger M; Schacter BA
    Cancer; 1998 Oct; 83(7):1344-54. PubMed ID: 9762935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients.
    Ribrag V; Dreyfus F; Venot A; Leblong V; Lanore JJ; Varet B
    Leuk Lymphoma; 1993 Jul; 10(4-5):317-21. PubMed ID: 8220129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Daver N; Thomas D; Ravandi F; Cortes J; Garris R; Jabbour E; Garcia-Manero G; Borthakur G; Kadia T; Rytting M; Konopleva M; Kantarjian H; O'Brien S
    Haematologica; 2015 May; 100(5):653-61. PubMed ID: 25682595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991.
    Yoshida M; Tsubaki K; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Minami S; Hiraoka A; Takahashi I; Naoe T; Asou N; Kageyama S; Tomonaga M; Saito H; Ohno R
    Int J Hematol; 1999 Dec; 70(4):261-7. PubMed ID: 10643152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
    De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
    Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy.
    Robertson MJ; Larson RA
    Am J Med; 1988 Feb; 84(2):233-9. PubMed ID: 3407652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient supportive care following chemotherapy for acute myeloblastic leukemia.
    Allan DS; Buckstein R; Imrie KR
    Leuk Lymphoma; 2001 Jul; 42(3):339-46. PubMed ID: 11699398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.
    Li MJ; Chang HH; Yang YL; Lu MY; Shao PL; Fu CM; Chou AK; Liu YL; Lin KH; Huang LM; Lin DT; Jou ST
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognostic value of respiratory events in acute leukemia.
    Chaoui D; Legrand O; Roche N; Cornet M; Lefebvre A; Peffault de Latour R; Sanhes L; Huchon G; Marie JP; Rabbat A
    Leukemia; 2004 Apr; 18(4):670-5. PubMed ID: 14762443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide.
    Bow EJ; Sutherland JA; Kilpatrick MG; Williams GJ; Clinch JJ; Shore TB; Rubinger M; Schacter BA
    J Clin Oncol; 1996 Apr; 14(4):1345-52. PubMed ID: 8648393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.